title: γδT-cell function in sepsis is modulated by C5a receptor signalling.
abstract: We previously showed that γδT cells are involved in the pathogenesis of sepsis, but, the underlying mechanisms remained unclear. The present study demonstrates, for the first time, that γδT cells express the complement C5a receptor (C5aR, CD88) and that CD88 expression in γδT cells was up-regulated in mice following sepsis both at protein and mRNA levels. Complement C5a itself contributed to the regulation of C5aR expression on γδT cells, as (i) neutralization of C5a in vivo prevented the expression of C5aR on γδT cells in septic mice and (ii) incubation of mouse spleen cells or purified γδT cells with recombinant C5a in vitro increased CD88 expression by γδT cells at both protein and mRNA levels. C5a receptor on γδT cells also mediates increased interleukin-17 (IL-17) expression as incubation of mouse spleen cells or purified γδT cells with recombinant C5a promotes the IL-17 expression by γδT cells. Ligation of the C5aR on γδT cells activated the phosphoinositide 3-kinase (PI3K)/Akt signalling pathway, which enhances CD88 expression and promotes IL-17 secretion. These results demonstrate that C5a acts directly on the C5aR expressed on γδT cells, resulting in cell activation, and subsequently enhances their capacity for IL-17 production. The up-regulation of the PI3K/Akt pathway following C5a stimulation contributes to up-regulation of γδT-cell function.
authors.affiliation: Department of Molecular Immunology, Institute of Basic Medical Sciences, Beijing, China. genchenghan@yahoo.com
authors.forename: Gencheng
authors.initials: G
authors.lastname: Han
authors.forename: Shaoxia
authors.initials: S
authors.lastname: Geng
authors.forename: Yurong
authors.initials: Y
authors.lastname: Li
authors.forename: Guojiang
authors.initials: G
authors.lastname: Chen
authors.forename: Renxi
authors.initials: R
authors.lastname: Wang
authors.forename: Xinying
authors.initials: X
authors.lastname: Li
authors.forename: Yuanfang
authors.initials: Y
authors.lastname: Ma
authors.forename: Beifen
authors.initials: B
authors.lastname: Shen
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D015936:Complement C5a / Q000276:immunology* / Q000494:pharmacology; D005434:Flow Cytometry; D007155:Immunologic Factors / Q000494:pharmacology; D020381:Interleukin-17 / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D044087:Receptor, Anaphylatoxin C5a / Q000235:genetics / Q000276:immunology*; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000276:immunology*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018805:Sepsis / Q000276:immunology*; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology*; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D007155:Immunologic Factors; D020381:Interleukin-17; D044087:Receptor, Anaphylatoxin C5a; D016692:Receptors, Antigen, T-Cell, gamma-delta; D011994:Recombinant Proteins; D015936:Complement C5a